Publication date: Dec 01, 2024
After the outbreak of the novel coronavirus at the end of December 2019 in China, it has become a global pandemic. Clinical manifestation of coronavirus disease 2019 (COVID-19) has a wide range of presentations from asymptomatic to severe multi-organ involvement. Hemoptysis appears to be one of the major manifestations of severe acute respiratory syndrome that is related to COVID-19 infection. The occurrence of hemoptysis is multifactorial. However, massive hemoptysis is usually related to pulmonary aspergillosis or severe bronchiectasis due to corticosteroid pulse therapy that can be life-threatening. This manuscript presents five cases of successful life-saving bronchial artery embolization in patients with COVID-19 infection who were suffering from massive hemoptysis that was mostly related to aspergillosis and bronchiectasis. These cases are followed by a review of the literature.
Open Access PDF
Concepts | Keywords |
---|---|
China | angioembolization |
Coronavirus | bronchiectasis |
December | embolization |
Massive | hemoptysis |
Therapy | invasive pulmonary aspergillosis |
polyvinyl alcohol | |
SARS-Cov-2 |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | COVID-19 |
disease | MESH | severe acute respiratory syndrome |
disease | MESH | infection |
disease | MESH | pulmonary aspergillosis |
disease | MESH | bronchiectasis |
disease | MESH | aspergillosis |
disease | MESH | invasive pulmonary aspergillosis |
drug | DRUGBANK | Polyvinyl alcohol |